Skip to main content
Clinical Trials/DRKS00022825
DRKS00022825
Completed
未知

Investigation of the metabolism and toxicokinetics of the surfactant 2,4,7,9-tetramethyl-5-decyne-4,7-diol (TMDD) in humans - TMDD

Verband der Chemischen Industrie e.V.0 sites4 target enrollmentOctober 30, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Exposition of humans with TMDD
Sponsor
Verband der Chemischen Industrie e.V.
Enrollment
4
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 30, 2020
End Date
January 22, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Verband der Chemischen Industrie e.V.

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Allergic persons
  • expectant mothers
  • breast\-feeding mothers

Outcomes

Primary Outcomes

Not specified

Similar Trials